BELLUS Health Inc. (BLU) Stock Price & Growth Analysis

New

Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now

You have successfully sign out

BELLUS Health Inc.

BLU

NASDAQ

Unprofitable

EPS improving

Unprofitable

EPS improving

Biotechnology

14.74USD

0.01 ( 0.03%)

Pre-market 14.74$

-0.01 (-0.03%)

Market Closed (as of Jun 28, 19:59 EDT)

Relative Strenght

Volume Buzz

-47%

Earning Acce

Yes

Dist 52w H.

Overview Chart

Quote Panel

Updated May 9, 2025

1W % 1M % 3M % 1Y %

Key Metrics

Market Cap
1.87B
Shares Outstanding
126.81M
Share in Float
92.13M
Dividende
0

Earning Date
No Data
Price Target
14.745
Average Volume
5.38M
Beta
-0.27898

Range
6.38-14.76
Industry
Biotechnology
Website
https://www.bellushealth.com
Sector
Healthcare

Quote Panel

Updated May 9, 2025

1W % 1M % 3M % 1Y %

Key Metrics

Market Cap
Shares Outstanding
Share in Float
Dividende

Earning Date
No Data
Price Target
Average Volume
Beta

Range
Industry
Website
Sector

Fundamentals

N/A

P/E Ratio

0.59x

P/S Ratio

4.89x

P/B Ratio

0.0

Debt/Equity

-2.0%

Net Margin

$-0.7

EPS

How BLU compares to sector?

P/E Ratio

Fundamentals

Relative Strength

BLU

Sector

Top 5 RS in Group

Symbol	Company	RS	5-Day Perf.

Relative Strength

BLU

Sector

Top 5 RS in Group

Symbol	Company	RS	5-Day Perf.

Forecast

No Data Available

Analyst rating

Strong Sell

Sell

Buy

Neutral

Strong Buy

Buy

Price Target

0.00(-100.00%)

Number of analyst

Last analyst upgrade/downgrade

RBC Capital

downgrade

Previous: Outperform

2023-04-18

Now: Sector Perform

Forecast

Analyst rating

Last analyst upgrade/downgrade

Earnings Growth

YoY

Current

Estimates

Q2.21

N/A

-0.23
vs -0.14

Q3.21

N/A

-0.29
vs -0.09

Q4.21

N/A

-0.18
vs -0.11

Q1.22

N/A

-0.13
vs -0.20

Q2.22

N/A

-0.18
vs -0.23

Q3.22

N/A

-0.20
vs -0.29

Q4.22

N/A

-0.12
vs -0.18

Q1.23

N/A

-0.20
vs -0.13

Q2.23

N/A

-0.18
vs -0.18

Q3.23

N/A

-0.08
vs -0.20

Sales Growth

YoY

Current

Estimates

Q2.21

4K vs 4K

Q3.21

+33%

4K vs 3K

Q4.21

4K vs 4K

Q1.22

4K vs 4K

Q2.22

4K vs 4K

Q3.22

4K vs 4K

Q4.22

4K vs 4K

Q1.23

-25%

3K vs 4K

Q2.23

+38054491%

1.5B vs 4K

Q3.23

+41278851%

1.7B vs 4K

Return on Equity

QoQ

Q4.21

-5%

-0.05
vs -0.24

Q1.22

-5%

-0.05
vs -0.05

Q2.22

-7%

-0.07
vs -0.05

Q3.22

-6%

-0.06
vs -0.07

Q4.22

-5%

-0.05
vs -0.06

Q1.23

-7%

-0.07
vs -0.05

Q2.23

-2%

-0.02
vs -0.07

Q3.23

-4%

-0.04
vs -0.02

Institutionnal Ownership

QoQ

Q4.21

108

108
vs 65

66%

Q1.22

90
vs 108

-17%

Q2.22

102

102
vs 90

13%

Q3.22

120

120
vs 102

18%

Q4.22

126

126
vs 120

Q1.23

108

108
vs 126

-14%

Q2.23

12
vs 108

-89%

Q3.23

1
vs 12

-92%

Earnings Growth

Latest News

proactiveinvestors.com

10 hours ago

Bellus Health shareholders say yes to US$2B GSK takeover

businesswire.com

13 hours ago

BELLUS Health Inc. Announces Voting Results from Special Meeting of Shareholders

businesswire.com

16 hours ago

BELLUS Health Reports First Quarter 2023 Financial Results and Business Highlights

businesswire.com

17 hours ago

Alliance Entertainment Reports Third Quarter and Nine Month Fiscal 2023 Financial Results

businesswire.com

17 hours ago

BELLUS Santé inc. convoque une assemblée extraordinaire des actionnaires concernant l’acquisition de la société par GSK

businesswire.com

17 hours ago

BELLUS Health Inc. Calls Special Shareholders' Meeting in Connection with GSK Acquisition

Company Description

14.74USD

N/A

0.59x

4.89x

0.0

-2.0%

$-0.7

Earnings Growth

Latest News

Company Description

14.74USD

N/A

0.59x

4.89x

0.0

-2.0%

$-0.7